article

Pharmaceutical Salts

Journal of Pharmaceutical Sciences · 1977 · Vol. 66(1) · pp. 1–19

Stephen M. Berge(Pfizer (United States))Lyle D. Bighley(Pfizer (United States))Donald C. Monkhouse✉(Pfizer (United States))

View via DOI Publisher page

Analytical Methods in Pharmaceuticals Potassium and Related DisordersChemistryStereochemistryPharmacologyMedicine

MeSH terms

AnimalsBiological AvailabilityChemistry, PharmaceuticalDialysisDrug StabilityPharmaceutical PreparationsHumansIntestinal AbsorptionKineticsMathematicsModels, ChemicalSaltsSolubilityStructure-Activity RelationshipTaste

Citations

472

FWCI

0.94

field-weighted impact

References

Percentile

76%

vs. same field & year

Citations per year

Cited by

Effects of Crystal Form on Solubility and Pharmacokinetics: A Crystal Engineering Case Study of Lamotrigine

Crystal Growth & Design · 2009 · 247 citations

Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals

Crystal Growth & Design · 2011 · 977 citations

Pharmaceutical cocrystals: along the path to improved medicines

Chemical Communications · 2015 · 902 citations

Polymorphs, Salts, and Cocrystals: What’s in a Name?

Crystal Growth & Design · 2012 · 1,018 citations

Pharmaceutical cocrystals and poorly soluble drugs

International Journal of Pharmaceutics · 2012 · 592 citations

Pharmaceutical Co-Crystals

Journal of Pharmaceutical Sciences · 2006 · 955 citations

Salt formation to improve drug solubility

Advanced Drug Delivery Reviews · 2007 · 1,380 citations

References

The pharmacological basis of therapeutics

American Heart Journal · 1941 · 1,909 citations

Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.